Novavax Files for COVID-19 Vaccine Authorization with Health Canada and Completes Submission for Rolling Review to European Medicines Agency

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/22/2026

1. SPY
2. WBD
3. PSKY
4. NVDA
5. TSLA
6. USO
7. AMD
8. META
9. AMC
10. COHR

Go back to Novavax Files for COVID-19 Vaccine Authorization with Health Canada and Completes Submission for Rolling Review to European Medicines Agency
Novavax, Inc. (NASDAQ: NVAX) Delayed: 10.41 +0.30 (2.97%)
Previous Close $10.11    52 Week High $9.23 
Open $10.38    52 Week Low $1.16 
Day High $10.70    P/E N/A 
Day Low $10.21    EPS $-0.30 
Volume 6,135,225